Article Text
Therapeutics/Prevention
Randomised controlled trial
Interruption of all anticoagulation is non-inferior to the use of short-term parenteral bridging in patients with atrial fibrillation undergoing invasive procedures
Statistics from Altmetric.com
Footnotes
Competing interests BAS reports research support from Janssen Pharmaceuticals.
Provenance and peer review Commissioned; internally peer reviewed.